2024 Conference Agenda
Philadelphia, PA, 5 - 6 September 2024
Schedule
Create your personal agenda –check the favourite icon
Sep 58:40
Conference pass
Opening Remarks from Terrapinn
Keynotes
Opening Remarks from Terrapinn
Sep 58:45
Conference pass
Chairperson's Opening Remarks
Keynotes
Recored remarks from Congressman Mike Levin
Sep 59:00
Conference pass
Keynote Opening Plenary: Never Surrender: Mobilizing the Global Fight Against Antibiotic Resistance
Keynotes
Sponsored by Recce Pharmaceuticals
Moderator: Erika Edwards, Health and Medical Reporter and Writer, NBC News
Wes Kim, Director of Global Public Health Programs, American Society for Microbiology
Alan W Dunton MD, Non-Executive Director, Recce Pharmaceuticals
Sep 59:20
Conference pass
Keynote Plenary: To be announced
Keynotes
Reserved for WHO
Sep 59:40
Conference pass
Keynote Plenary: Strengthening Global Health Architecture to Readily Respond to the Next Health Emergency
Keynotes
Other speakers to be announced
Moderator: Carolyn Reynolds, Co-Founder, Pandemic Action Network
David Boucher, Director, Infectious Disease Preparedness & Response, Biomedical Advanced Research And Development Authority
Riko Kimoto, Head, Public Health Network, Asia-Europe Foundation
Wolfgang Philipp, Principal Adviser, Chief Science Officer, European Commission Health Emergency Preparedness & Response (HERA)
Sep 510:15
Conference pass
Keynote Plenary: To be announced
Keynotes
Sponsored by GSK
Sep 510:50
Conference pass
Morning Networking Break & Expo Hall Opens
Break
Morning Networking Break & Expo Hall Opens
Sep 511:15
Conference pass
Chair Person
Antibiotic Development
Bradley Burnam, Founder/Chief Executive Officer, Patient Advocate & Founder
Sep 511:15
Conference pass
Chair Person
AMR Diagnostics
Cepheid representative to be announced
Sep 511:15
Conference pass
Sep 511:15
Conference pass
Chair Person
Innovation Showcase
To be announced
Sep 511:15
Conference pass
Chair Person
Impact, Policy, & Awareness
Sep 511:15
Conference pass
Chair Person
One Health
Francesca Chiara, Director of Antimicrobial Resistance Stewardship, Center for Infectious Disease Research & Policy (CIDRAP)
Sep 511:15
Conference pass
Chair Person
Vaccines (DPC)
Harry Kleanthous, Executive Vice President, Vaccines R&D Strategy & External Innovation, SK Bioscience
Sep 511:15
Conference pass
Chair Person
New Technology (DPC)
Rick Bright, Founder, Bright Global Health
Sep 511:15
Conference pass
Sep 511:20
Conference pass
Panel: Building the Framework: Sustainable Lab Strengthening in LMICs
Antibiotic Stewardship
Moderator: Wes Kim, Director of Global Public Health Programs, American Society for Microbiology
Patrick Mateta, Board Chairman, African Society for Laboratory Medicine
Sep 511:20
Conference pass
Presentation: A Way Forward: Operationalizing One Health
One Health
Lesley Ogilvie, Director, Global AMR R&D Hub
Sep 511:20
Conference pass
Presentation: DISEASE X- The 100 Days Mission to End Pandemics
Vaccines (DPC)
Kate Kelland, Chief Scientific Writer, Coalition for Epidemic Preparedness Innovations
Sep 511:20
Conference pass
Presentation: How Can Current Reimbursement Models be Leveraged While Waiting for ‘Pull’ Incentives?
Impact, Policy, & Awareness
Sponsored by Debiopharm
Jennifer Quinn, Head of Global Value and Access, Debiopharm International
Sep 511:20
Conference pass
Presentation: Novel DNA pol IIIC Inhibitors for Gram-positive Bacterial Infections: Lead Product Candidate ibezapolstat Advancing to Phase 3 Trials
Innovation Showcase
Robert DeLuccia, Executive Chairman, Acurx Pharmaceuticals
Sep 511:20
Conference pass
Presentation: Project NextGen: Enhancing Preparedness with Next Generation Medical Countermeasures
Global Collaboration & Partnership (DPC)
Robert Johnson, Director, Medical Countermeasures Programs, HHS/BARDA
Sep 511:20
Conference pass
Presentation: Pull Incentives for AMR Diagnostics
AMR Diagnostics
Sep 511:20
Conference pass
Presentation: To be announced
Antibiotic Development
Sponsored by Recce Pharmaceuticals
Sep 511:20
Conference pass
Presentation: Upscaling Innovation: Bringing Visibility Into Vaccines Supply Chains Within LMICs
New Technology (DPC)
Souleymane Sawadogo, Chief Global Heath Officer, Parsyl
Sep 511:40
Conference pass
Panel: Navigating the Future: Strategies and Challenges in AMR Policy Development
Impact, Policy, & Awareness
Moderator: Taylor Sexton, Executive Director, Medical Countermeasures Coaltion
Deepali Patel, Director of International Policy, AMR Action Fund
David McKinney, Co-founder & Director, ARMOR - Alliance for Reducing Microbial Resistance
Paul Plummer, Executive Director, National Institute of Antimicrobial Resistance Research and Education (NIAMRRE)
Sep 511:40
Conference pass
Panel: Overuse of ABT in the Outpatient Space - Minimizing Data Gaps & Increasing Antibiotic Stewardship
AMR Diagnostics
Sponsored by Biomerieux
Sep 511:40
Conference pass
Presentation: Breaking Barriers in Antivirals : Xafty's Singular Solution for Multiple Respiratory Viral Infections
New Technology (DPC)
Heung Jeong Woo, Executive Vice President, Hyundai Bioscience
Sep 511:40
Conference pass
Presentation: Telementoring, Equity and Advocacy Collaboration for Health through Antimicrobial Stewardship
Antibiotic Stewardship
Amy Groom, Director of Immunization Initiatives, University of New Mexico Health Sciences Center, ECHO Institute
Sep 511:40
Conference pass
Presentation: To be announced
Antibiotic Development
To be announced
Sep 511:40
Conference pass
Presentation: To be announced
Innovation Showcase
Sponsored by CosmoID
Sep 511:40
Conference pass
Presentation: To be announced
One Health
To be announced
Sep 511:40
Conference pass
Presentation: To be announced
Vaccines (DPC)
To be announced
Sep 511:40
Conference pass
Presentation: To be announced
Global Collaboration & Partnership (DPC)
To be annoucned
Sep 512:00
Conference pass
Panel: A One Health Approach: Wastewater Surveillance for AMR
One Health
Sponsored by Resistomap
Moderator: Francesca Chiara, Director of Antimicrobial Resistance Stewardship, Center for Infectious Disease Research & Policy (CIDRAP)
Claudio Ternieden, Executive Director, Water & Wastewater Equipment Manufacturers Association (WWEMA)
Amy E. Kirby, PhD MPH, Rapid Response Research and Surveillance Branch (Acting Approved), Division of Infectious Disease Readiness and Innovation, CDC
Nichole Brinkman, Biologist, US Environmental Protection Agency
Windi Muziasari, Chief Executive Officer, Resistomap
Sep 512:00
Conference pass
Panel: Innovation in Public-Private Partnership to Combat Endemic Infectious Disease
Global Collaboration & Partnership (DPC)
Other speakers to be announced
Sep 512:00
Conference pass
Panel: Modernizing Incentive Structures: A Roadmap to Strengthen Antimicrobial Development
Antibiotic Development
Other speakers to be announced
Moderator: Ralf Mr Sudbrak, Deputy Director, Global AMR R&D Hub
Sep 512:00
Conference pass
Panel: Navigating the Landscape - Strategies for Early-Stage Developmental Funding
Innovation Showcase
Other speakers to be announced
Moderator: Douglas Häggström, Management Team, INCATE
Sep 512:00
Conference pass
Panel: The Role of AI for Pandemic Preparedness
New Technology (DPC)
Moderator: Rick Bright, Founder, Bright Global Health
Charles Holmes, Director of the Georgetown Center for Innovation in Global Health, Georgetown University
Claire Wagner, Head of Corporate Strategy & Market Access, Bill and Melinda Gates Medical Research Institute
Sep 512:00
Conference pass
Presentation: Incorporating Social Dynamics in Antimicrobial Stewardship Implementation
Antibiotic Stewardship
Sep 512:00
Conference pass
Preventing Zoonotic Spillover: The Role of Novel Next-Generation Animal Vaccines
Vaccines (DPC)
Other panelists to be announced
Moderator: Harry Kleanthous, Executive Vice President, Vaccines R&D Strategy & External Innovation, SK Bioscience
Sep 512:20
Conference pass
Presentation: FebriDx; A Rapid Point-of-Care Test Tool to Aid Clinicians in the Reduction of Antibiotic Misuse in Acute Respiratory Infections
AMR Diagnostics
Sponsored by Lumos Diagnostics
Sep 512:20
Conference pass
Presentation: How Innovation drives Awareness, changes Policy and makes an Impact (draft)
Impact, Policy, & Awareness
Sponsored by GSK
Sep 512:50
Conference pass
Keynote Plenary: To be announced
Keynotes
To be announced
Sep 513:30
Conference pass
Roundtable 5: To be announced
Roundtable
Troy Skwor, Associate Professor, University of Wisconsin - Milwaukee
Sep 513:30
Conference pass
Roundtable 1: Certification Opportunities in Infection Prevention and Control: A Roundtable Discussion with the Certification Board of Infection Control & Epidemiology
Roundtable
Jessica Dangles, Executive Director - CBIC, Association for Professionals in Infection Control and Epidemiology
Sep 513:30
Conference pass
ROUNDTABLE 1: Certification Opportunities in Infection Prevention and Control: A Roundtable Discussion with the Certification Board of Infection Control & Epidemiology
Roundtable
Jessica Dangles, Executive Director - CBIC, Association for Professionals in Infection Control and Epidemiology
Sep 513:30
Conference pass
Roundtable 10: To be announced
Roundtable
Reserved for Shionogi
Sep 513:30
Conference pass
Roundtable 2: Successful Implementation of Community Health Programs : A Look Into Cardiovascular Health Initiative (CHI)
Roundtable
Sep 513:30
Conference pass
Roundtable 3: Diagnostics to Inform Patient Management and Antimicrobial Stewardship
Roundtable
Matthew Davenport, Project Officer, HHS/OS/ASPR/BARDA
Sep 513:30
Conference pass
Roundtable 4: Pathogen Emergence: Understanding the Movement Between Plants, Animals, & Humans
Roundtable
Vanessa Varaljay, Strategic Alliance Officer - Infectious Diseases Institute, The Ohio State University
Sep 513:30
Conference pass
Roundtable 5: To be announced
Roundtable
To be announced
Sep 513:30
Conference pass
Roundtable 6: What Data is Needed to Fit Current Payer Evidence Requirements and How Can we Generate it
Roundtable
Sponsored by Debiopharm
Jennifer Quinn, Head of Global Value and Access, Debiopharm International
Sep 513:30
Conference pass
Roundtable 7: To be announced
Roundtable
Sponsored by Cepheid
Sep 513:30
Conference pass
Roundtable 8: To be announced
Roundtable
Sponsored by Takara Bio
Sep 513:30
Conference pass
Roundtable 9: A Broad Spectrum Antiviral: Xafty for Future Pandemic Preparedness
Roundtable
Dr. Geun-woo Jin, Director of Research & Development, Hyundai Bioscience
Dr. C. Jo White, Medical Advisor, Hyundai Bioscience
Sep 514:10
Conference pass
Chair Person
Antibiotic Development
Bradley Burnam, Founder/Chief Executive Officer, Patient Advocate & Founder
Sep 514:10
Conference pass
Chair Person
AMR Diagnostics
Reserved for Cepheid
Sep 514:10
Conference pass
Sep 514:10
Conference pass
Chair Person
Innovation Showcase
To be announced
Sep 514:10
Conference pass
Chair Person
Impact, Policy, & Awareness
Sep 514:10
Conference pass
Chair Person
One Health
Francesca Chiara, Director of Antimicrobial Resistance Stewardship, Center for Infectious Disease Research & Policy (CIDRAP)
Sep 514:10
Conference pass
Chair Person
Vaccines (DPC)
Harry Kleanthous, Executive Vice President, Vaccines R&D Strategy & External Innovation, SK Bioscience
Sep 514:10
Conference pass
Chair Person
New Technology (DPC)
Rick Bright, Founder, Bright Global Health
Sep 514:10
Conference pass
Sep 514:10
Conference pass
Short Break Before Track Sessions Resume
Break
Short Break Before Track Sessions Resume
Sep 514:15
Conference pass
Fireside Chat: Institutional investors: Allies in the fight against AMR
One Health
Emma Berntman, Senior Engagement Specialist AMR, FAIRR Initiative
Sep 514:15
Conference pass
Panel: AMR Awareness: The Next Important Step in Our Battle
Impact, Policy, & Awareness
Sponsored by Recce Pharmaceuticals
Sep 514:15
Conference pass
Panel: Global Innovator Panel for Preparedness
New Technology (DPC)
Moderator: Prashant Yadav, Affiliate Professor of Technology & Operations Management and Faculty Director, Africa Initiative, Insead
Dino Rech, Chief Executive Officer, Audere
Sep 514:15
Conference pass
Panel: To be announced
Antibiotic Stewardship
To be announced - Reserved for Pfizer
Sep 514:15
Conference pass
Presentation: AI for Antibiotic Development
Antibiotic Development
César De La Fuente, Presidential Assistant Professor, University of Pennsylvania
Sep 514:15
Conference pass
Presentation: Evaluating Vaccine Efficacy Against Emerging Pathogens: Standardized Assay Development
Vaccines (DPC)
Ali Azizi, Project Lead, CEPI
Sep 514:15
Conference pass
Presentation: To be announced
AMR Diagnostics
To be announced
Sep 514:15
Conference pass
Presentation: To be announced
Global Collaboration & Partnership (DPC)
Rachel Rath, BARDA Alliance Director, Johnson & Johnson Innovation
Sep 514:15
Conference pass
Presentation: To be announced
Innovation Showcase
To be announced
Sep 514:35
Conference pass
Presentation: Betting on the right therapeutic phage using high-performance bioinformatic
Innovation Showcase
Sponsored by Rime Bioinformatics
Antoine Culot, President, Rime Bioinformatics
Sep 514:35
Conference pass
Presentation: Precision Microbiome Engineering as an Alternative to Antibiotics to Prevent Bacterial Infections in Agriculture
One Health
Sep 514:35
Conference pass
Presentation: To be announced
Antibiotic Development
Reserved for Pfizer
Sep 514:35
Conference pass
Presentation: To be announced
AMR Diagnostics
To be announced
Sep 514:35
Conference pass
Presentation: To be announced
Global Collaboration & Partnership (DPC)
To be announced
Sep 514:35
Conference pass
Presentation: To be announced
Vaccines (DPC)
To be announced
Sep 514:55
Conference pass
Panel: Effective Public Private Partnerships for Pandemic Response
Global Collaboration & Partnership (DPC)
Reserved for BioNtech
Sep 514:55
Conference pass
Panel: Building a Common Agenda for AMR: Finding the Overlap Between LMICs and High- Middle Income Countries
Impact, Policy, & Awareness
ICARS representative to be announced.
Moderator: Dana McLaughlin, Special Assistant to the Deputy Director and Chief of Staff, The White House
Henry Skinner, Chief Executive Officer, AMR Action Fund
Mirfin Mpundu, Director, React Africa
Sep 514:55
Conference pass
Panel: Cross-Sector Engagement: One Health AMR Success Stories
One Health
Moderator: Kris Johansen, Associate Director of External Relations, National Institute of Antimicrobial Resistance Research and Education (NIAMMRE)
Jolieke van Oosterwijk, Chief Scientific Officer, US Biologic
Hassanatu Blake, Director, Health Equity & Social Justice, NACCHO
Steven Harris, Chair -Department of Plant Pathology, Entomology and Microbiology, Iowa State University
Sep 514:55
Conference pass
Panel: Patient-Centric Approaches in the AMR Drug Pipeline
Antibiotic Development
Jonathan Pearce, Chief Executive Officer, Antibiotic Research UK
Bradley Burnam, Founder/Chief Executive Officer, Patient Advocate & Founder
Ella Balasa, Patient Advocate, Patient Advocate
Sep 514:55
Conference pass
Panel: The Role of Machine Learning & AI for Vaccine Delivery
Vaccines (DPC)
Panelists to be announced
Sep 514:55
Conference pass
Panel: The Role of the IP, Nurse and Nurse Practitioner: Driving Antimicrobial Stewardship at the Bedside
Antibiotic Stewardship
Moderator: Kim Abbass, Clinical Coordinator Antimicrobial Stewardship and Pharmacy Practice, Eastern Zone,, Nova Scotia Health
Mary Lou Manning, Director, Center for Infection Prevention and Antibiotic Stewardship, Thomas Jefferson University
Sep 514:55
Conference pass
Panel: To be announced
AMR Diagnostics
Sponsored by Cepheid
Sep 514:55
Conference pass
Panel: To be announced
Innovation Showcase
To be announced
Sep 514:55
Conference pass
Presentation: To be announced
New Technology (DPC)
Sponsored by Cocentric by Ginkgo
Sep 515:15
Conference pass
Presentation: Evaluating Vaccine Efficacy Against Emerging Pathogens: Standardized Assay Development
New Technology (DPC)
Ami Patel, Assistant Professor, The Wistar Institute
Sep 515:35
Conference pass
Short Break Before Keynotes
Break
Short Break Before Keynotes
Sep 515:45
Conference pass
Afternoon Chairperson Opening Remarks
Keynotes
To be announced
Sep 515:50
Conference pass
Keynote Plenary: Implementing the 100 Day Mission into Action: Where are we Now?
Keynotes
Other panelists to be announced
Sep 516:30
Conference pass
Keynote Panel: From Awareness to Action: Identifying Tailored Solutions for AMR
Keynotes
Reserved for Menarini
Michael Craig, Senior Advisor for Antimicrobial Resistance, Antimicrobial Resistance Coordination and Strategy Unit, Centers for Disease Control and Prevention
Diane Shader Smith, Independent Public Relations and Communications Professional, Patient Advocate
Sep 517:10
Conference pass
Keynote Panel: Global Champions for AMR: Shaping Narratives and Influencing Policy with the First Taskforce of AMR Survivors
Keynotes
Anthony Darcovich, Patient advocate, WHO Patient Survivor’s Taskforce
Nour Shamas, Chairperson, Antimicrobial Stewardship Committee - Riyadh, National Guard Health Affairs
Ella Balasa, Patient Advocate, Patient Advocate
Rob Purdie, Founder and Managing Director, Mycology Advocacy, research and Education (MyCARE)
Create your personal agenda –check the favourite icon
Sep 68:00
Conference pass
Registration opens
Keynotes
Registration opens
Sep 68:40
Conference pass
Keynote: Chairperson’s Opening Remarks
Keynotes
Jomana Musmar, Executive Director, Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria, DHHS
Sep 68:45
Conference pass
Keynote Address: AMR: Tackling a Silent Pandemic with a One-Health Approach
Keynotes
Sponsored by bioMerieux
Brian Raux, Medical Advisor, Biomerieux
Sep 69:05
Conference pass
Keynote Panel: Putting AMR on the Global Agenda: Setting Targets, Accelerating Action, and Ensuring Accountability
Keynotes
Sponsored by Pfizer
Other panelists to be announced.
Jeremy Knox, Head of Policy, Infectious Diseases, Wellcome Trust
Sep 69:40
Conference pass
Keynote Plenary: Why the World Needs Its Own Immune System
Keynotes
Sponsored by Cocentric by Ginkgo
Moderator: Kate Kelland, Chief Scientific Writer, Coalition for Epidemic Preparedness Innovations
Sep 610:20
Conference pass
Expo and Networking Break
Break
Expo and Networking Break
Sep 610:55
Conference pass
Chair Person
Antibiotic Commercalization
To be announced
Sep 610:55
Conference pass
Chair Person
AMR Diagnostics
Reserevd for Cepheid
Sep 610:55
Conference pass
Chair Person
AMR Vaccines
To be announced
Sep 610:55
Conference pass
Chair Person
Innovation Showcase
To be announced
Sep 610:55
Conference pass
Chair Person
Impact, Policy, & Awareness
Marjorie Korn, Deputy Communications Director, AMR Action Fund
Sep 610:55
Conference pass
Chair Person
Genomics & Surveillance
To be announced
Sep 610:55
Conference pass
Chair Person
Infection Prevention
To be announced
Sep 610:55
Conference pass
Chair Person
Diagnostics & Surveillance (DPC)
To be announced
Sep 610:55
Conference pass
Chair Person
Funding & Preparedness (DPC)
Sep 611:00
Conference pass
Fireside Chat: A New Grand Bargain to Improve the Antimicrobial Market for Human Health
Antibiotic Commercalization
Javier Guzman, Director, Global Health Policy, Center for Global Development
Sep 611:00
Conference pass
Investors Panel: Seeking Returns from Investing in Anti-Infectives
Innovation Showcase
Moderator: Aleks Engel, Director, REPAIR Impact Fund, Novo Holdings
Martin Heidecker, Chief Investment Officer, AMR Action Fund
Mark Bamforth, General Partner, Kineticos AMR Accelerator Fund I, Kineticos Life Sciences
Bita Sehat, Senior Investment Director, Trill Impact Ventures
Fei Shen, Investment Director, Boehringer Ingelheim Venture Fund
Sep 611:00
Conference pass
Panel: Investing in Global Health Securit
Funding & Preparedness (DPC)
Other panelists to be announced
Moderator: Justin Yang, Co-Founder, Kaibab Health & DMV Bio
Kevan Oconnor, Venture Investor, Cystic Fibrosis Foundation
Sep 611:00
Conference pass
Panel: To be announced
AMR Vaccines
Reserved for CARB-X
Sep 611:00
Conference pass
Presentation: Breaking Down Barriers: Health Equity Strategies for Underrepresented Communities
Impact, Policy, & Awareness
Jovonni Spinner, Chief Executive Officer & Founder, Beacon Public Health
Sep 611:00
Conference pass
Presentation: Bridging the gap: Transitioning Rapid Detection Methods for Food Safety Use
AMR Diagnostics
Cheryl Armstrong, Research Microbiologist, USDA
Sep 611:00
Conference pass
Presentation: Infectious Disease Detection and Surveillance Project
Diagnostics & Surveillance (DPC)
Lindsey Shields, Deputy Director, Epidemic Prepardness and Response, PATH
Sep 611:00
Conference pass
Presentation: Playing Catch- Up: What Happened When I Made the Wrong Call- A Mycobacterium Tuberculosis Case Study
Infection Prevention
Margaret Gilman, Director, Infection Prevention and Control, Nemours Children's Hospital, Delaware
Sep 611:00
Conference pass
Presentation: Tackling Antimicrobial Resistance in Healthcare: The Significance of Robust Health and Economic Data
Genomics & Surveillance
Sep 611:20
Conference pass
Panel: Women's Health: AMR Today & More Importantly, Tomorrow
Impact, Policy, & Awareness
Moderator: Beth Battaglino, Chief Executive Officer, HealthyWomen
Carolyn Reynolds, Co-Founder, Pandemic Action Network
Uzma Syed, Board Member, Sepsis Alliance
Sep 611:20
Conference pass
Panel: Everything, Everywhere, All at Once. Why the Common Thread in Resistant, Infectious Diseases may be Biofilms
Infection Prevention
Sponsored by N8 Medical
Moderator: Ted Buckley, Vice President, Government Relations, Shionogi Inc.
Maud Eijkenboom, Managing Director, Lixa
Diane Shader Smith, Independent Public Relations and Communications Professional, Patient Advocate
Sep 611:20
Conference pass
Panel: To be announced
Antibiotic Commercalization
To be announced
Sep 611:20
Conference pass
Presentation: A Future Call on Diagnostics: Addressing the Global Antimicrobial & Diagnostic Pipeline through the UK PACE Initiative
AMR Diagnostics
Sep 611:20
Conference pass
Presentation: To be announced
Genomics & Surveillance
Sponsored by Takara Bio
Sep 611:20
Conference pass
Presentation: To be announced
Diagnostics & Surveillance (DPC)
To be announced
Sep 611:40
Conference pass
Panel: Pandemic Risks, Management, & Mitigation: Conversations With Local & Global Health Officials
Diagnostics & Surveillance (DPC)
USAID representative to be announced
Meredith Allen, Vice President, Health Security, Association of State and Territorial Health Officials (ASTHO)
Syra Madad, Senior Director, System-wide Special Pathogens Program, NYC Health + Hospitals
Sep 611:40
Conference pass
Panel: The Economic Burden of AMR
Genomics & Surveillance
Other speakes to be announced
Anthony McDonnell, Senior Policy Analyst, Center for Global Development
Sep 611:40
Conference pass
Panel: To be announced
AMR Diagnostics
Reserved for Clinton Health Access Initiative
Sep 611:40
Conference pass
Presentation: Future Breakthrough Therapy in the Prevention of AMR Infections - A Synthetic, Autonomous, AI-chosen Microbiome Based Biotherapeutic. Human Biome's Journey to Make it Real
Innovation Showcase
Sep 611:40
Conference pass
Presentation: Liposomal Encapsulation of Polysaccharides (LEPS) as an Effective Vaccine Strategy to Protect Aged Hosts Against S. pneumoniae Infection
AMR Vaccines
Manmeet Pal Singh Bhalla, Senior Research Scientist, University at Buffalo
Sep 611:40
Conference pass
Presentation: What’s next? Predicting and Preparing for the Next Pandemic
Funding & Preparedness (DPC)
Sep 611:50
Conference pass
Panel: Leveraging Partnerships for Antimicrobial Developments
Antibiotic Commercalization
Reserved for CARB-X representative
Moderator: John Alter, Head of External Affairs, AMR Action Fund
Yann Ferrisse, Director, Business Development & Partner Engagement, GARDP
Sep 612:00
Conference pass
Presentation: Building Trust & Reimagining Health for the 21st Century
Impact, Policy, & Awareness
Sep 612:00
Conference pass
Presentation: Engaging Ecosystems: Driving Political Actions & Commitments to Strengthen Pandemic Response
Funding & Preparedness (DPC)
Claire Wingfield, Director, Partnerships & Advocacy, FIND
Sep 612:00
Conference pass
Presentation: To be announced
AMR Vaccines
To be announced
Sep 612:00
Conference pass
Presentation: To be announced
Innovation Showcase
To be announced
Sep 612:20
Conference pass
Networking Break & Film Screening: HOLOBIOME
Break
What if you found out that, on a cellular level, you, your body at least, is more microbial than human. And what if it wasn’t just your body that is more microbial than it seems, but that almost everything, all life on earth, is made possible by microbes? The concept of the Holobiome captures this reality and also beckons us to reconsider our understanding of health and infectious disease, along with our relationship to the microbial world. This series currently features two innovative short films that explore this emergent, holobiome, understanding of life and health.
Film 1 Maddie's Transplant (20min) is a documentary featuring the harrowing tale of a young woman and her mother confronting what happens when the human immune system becomes compromised and the drugs stop working.
Film 2 Bradley's Burden (18min) is a sci-fi / documentary hybrid explores the future past of biotechnology and the need for innovation and more innovative thinking in our relationship with infectious diseases and the microbial world
Sep 613:00
Conference pass
Roundtable 1: To be annnounced
Roundtable
To be announced
Sep 613:00
Conference pass
Roundtable 10: To be announced
Roundtable
To be announced
Sep 613:00
Conference pass
Roundtable 2: AMR-related Grant Funding Through the Agency for Healthcare Research and Quality (AHRQ): Areas of Interest and Tips for Success
Roundtable
Susan Henderson, Medical Officer, AHRQ/ CQUiPS
Sep 613:00
Conference pass
Roundtable 3: Overcoming Misinformation and Restoring Trust in Public Health in Rural Tennessee Through Cinema
Roundtable
Mark Chee, Assistant Professor, University of Tennessee Southern
Sep 613:00
Conference pass
Roundtable 4: Targets and Accountability: How can Progress be Maintained in the Global Response to AMR Beyond this Year’s UN High-Level Meeting
Roundtable
Sep 613:00
Conference pass
Roundtable 5: Antibiotic stewardship in Veterinary Medicine: Progress and Remaining Challenges?
Roundtable
Laurel Redding, Assistant Professor of Epidemiology, University of Pennsylvania
Sep 613:00
Conference pass
Roundtable 6: Innovation for Broadband Anti-infectives Targeting Pandemic Preparedness and the Growing Challenge of Antimicrobial Resistance
Roundtable
Karsten Ottenberg, Chairman, AATec Medical
Sep 613:00
Conference pass
Roundtable 7: To be announced
Roundtable
To be announced
Sep 613:00
Conference pass
Roundtable 8: To be announced
Roundtable
To be announced
Sep 613:00
Conference pass
Roundtable 9: To be announced
Roundtable
To be announced
Sep 613:40
Conference pass
Chair Person
Antibiotic Commercalization
To be announced
Sep 613:40
Conference pass
Chair Person
Antibiotic Stewardship
To be announced
Sep 613:40
Conference pass
Chair Person
AMR Vaccines
To be announced
Sep 613:40
Conference pass
Chair Person
Innovation Showcase
To be announced
Sep 613:40
Conference pass
Chair Person
Fungals
To be announced
Sep 613:40
Conference pass
Chair Person
Genomics & Surveillance
To be announced
Sep 613:40
Conference pass
Chair Person
Infection Prevention
To be announced
Sep 613:40
Conference pass
Chair Person
Diagnostics & Surveillance (DPC)
To be announced
Sep 613:40
Conference pass
Chair Person
Funding & Preparedness (DPC)
Sep 613:40
Conference pass
Short Break Before Track Sessions Resume
Break
Short Break Before Track Sessions Resume
Sep 613:50
Conference pass
Panel: Development for Novel Decolonization Agents
Innovation Showcase
Speakers to be announced
John Jernigan, MD, MS, Chief, Epidemiology Research, and Innovations Branch, Centers for Disease Control and Prevention
Sep 613:50
Conference pass
Panel: Economic & Procurement Tools to Improve Antibiotic Access: SECURE and Other Initiative
Antibiotic Commercalization
Other speakers to be announced
Moderator: Javier Guzman, Director, Global Health Policy, Center for Global Development
Benjamin Park, Senior Specialist, AMR/ IPC, The Global Fund
Jennifer Cohn, Director, Global Access, Global Antibiotic Research & Development Partnership (GARDP)
Brenda Waning, Chief, Global Drug Facility (GDF)
Sep 613:50
Conference pass
Presentation: Adapting for Accessibility & Affordability: Saliva as a Sample Type to Overcome Testing Barriers for Better Outbreak Control.
Diagnostics & Surveillance (DPC)
Sep 613:50
Conference pass
Presentation: Candida auris: Turning Challenges into Successes at Your Healthcare Facility
Fungals
Sep 613:50
Conference pass
Presentation: From Bedside to Clinic: Navigating the Landscape of Antimicrobial Stewardship Challenges
Antibiotic Stewardship
Kevin Nguyen, Infectious Diseases Pharmacist & Associate Director of Antimicrobial Stewardship, St Christophers Hospital for Children
Sep 613:50
Conference pass
Presentation: Harnessing The Power of Genomics to Understand Antimicrobial Resistance Emergence in the Environment
Genomics & Surveillance
Thanh Nguyen, Professor, University of Illinois
Sep 613:50
Conference pass
Presentation: NIAD's Pandemic Preparedness Plan
Funding & Preparedness (DPC)
Jane Knisely, Pandemic Preparedness Strategy Coordinator, Division of Microbiology and Infectious Disease, NIAID, NIH
Sep 613:50
Conference pass
Presentation: To be announced
AMR Vaccines
Reserved for BacVax
Sep 614:10
Conference pass
Panel: Role of Certification in Reducing Risk of Infection and Transmission of AMR
Infection Prevention
Moderator: Jessica Dangles, Executive Director - CBIC, Association for Professionals in Infection Control and Epidemiology
Sep 614:10
Conference pass
Presentation: Clinicians Underutilize Novel Antibiotics in AMR Infections: What will it Take to Move the Dial?
Antibiotic Stewardship
Sameer Kadri, MD, ICU Physician and AMR Epidemiologist, NIH CLINICAL CENTER
Sep 614:10
Conference pass
Presentation: Developing First-in-class mAbs Targeting Novel, Fungal Cell Wall Proteins as Safer and Efficacious Therapies for Invasive Fungal Infections
Fungals
Soumya Palliyil, Head of Scottish Biologics Facility, University of Aberdeen
Sep 614:10
Conference pass
Presentation: The Challenges and Promise of Using Pan-Pathogen Diagnostics and Metagenomics for Surveillance and Discovery
Diagnostics & Surveillance (DPC)
Sep 614:10
Conference pass
Presentation: To be announced
Genomics & Surveillance
To be announced
Sep 614:10
Conference pass
Presentation: To be announced
AMR Vaccines
To be announced
Sep 614:10
Conference pass
Presentation: To be announced
Funding & Preparedness (DPC)
To be announced
Sep 614:30
Conference pass
Panel: From New Drug Developments to New Approaches: Tackling the Emerging Threat of Anti-fungal Resistance
Fungals
Moderator: Rob Purdie, Founder and Managing Director, Mycology Advocacy, research and Education (MyCARE)
Carol Munro, Professor, University of Aberdeen
Sep 614:30
Conference pass
Panel: Detecting and Correcting Misinformation Online - What's Next?
Funding & Preparedness (DPC)
Moderator: Erika Edwards, Health and Medical Reporter and Writer, NBC News
Eric Burnett, Hospitalist, Columbia University Irving Medical Center
Walter Straus, Vice President, Clinical Safety & Risk Management, Moderna Therapeutics
Katrine Wallace, Epidemiologist, University of Illlinois Chicago
Paul Offit, Physician, Childrens Hospital of Pennsylvania
Sep 614:30
Conference pass
Panel: Strengthening Antibiotic Regulation: Antimicrobial Resistance in Lower-Middle-Income Countries and its Global Implications
Antibiotic Commercalization
Amita Gupta, Director - Division of Infectious Diseases, Johns Hopkins University
Mirfin Mpundu, Director, React Africa
Sep 614:30
Conference pass
Panel: To be announced
AMR Vaccines
To be announced
Sep 614:30
Conference pass
Panel: To be announced
Diagnostics & Surveillance (DPC)
To be announced
Sep 614:30
Conference pass
Presentation: Agency for Healthcare Research and Quality (AHRQ) AMR-Related Activities: Research to Implementation
Antibiotic Stewardship
Susan Henderson, Medical Officer, AHRQ/ CQUiPS
Sep 614:30
Conference pass
Presentation: Next Steps: Standardizing Guidelines for Phage Susceptibility Testing
Innovation Showcase
Sep 614:30
Conference pass
Presentation:Cracking the Code: MDRO Surveillance Secrets Revealed
Genomics & Surveillance
Sean Brown, Associate Director of Infection Prevention & Control, NYC Health + Hospitals
Sep 614:50
Conference pass
Presentation: Impact of COVID on Consumption of Antimicrobials
Infection Prevention
Tauqeer Mustafa, Public Health Specialist, Fleming Fund
Sep 614:50
Conference pass
Presentation: Regulatory Considerations in the Development of Bacteriophage for Clinical Us
Innovation Showcase
Sep 614:50
Conference pass
Presentation: To be announced
Infection Prevention
To be announced
last published: 18/Apr/24 15:05 GMT
GET INVOLVED AT THE
WORLD ANTI-MICROBIAL RESISTANCE CONGRESS
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events